Insights
See our event recap
NEW
08/19/2026
More than compliance: Managing the challenges of controlled substance manufacturing
Read article
Recent
Jul 23, 2026
Scale-up
Drug Products
Dosage form scale-up: Balancing speed and efficiency in later-stage development
Jul 8, 2026
Early-phase development
Regulatory support
Navigating the complex route to regulatory compliance, from preclinical to market
Jun 22, 2026
Scale-up
Drug Products
The need for speed: Early-stage dosage form development
Subscribe for more expert insights
All posts
Aug 19, 2026
Early-phase development
Regulatory support
More than compliance: Managing the challenges of controlled substance manufacturing
Jul 8, 2026
Early-phase development
Regulatory support
Navigating the complex route to regulatory compliance, from preclinical to market
Jan 22, 2026
Early-phase development
The power of derivatization: Simple solutions to complex analytical problems
Oct 2, 2025
Early-phase development
4 reasons early-phase drug development in the US gives US pharma a competitive edge
Jul 10, 2025
Early-phase development
Accelerate drug development with phase-appropriate thinking
Mar 21, 2025
Early-phase development
Ask better, move faster: Questions that will accelerate the speed of your program to clinical
Oct 30, 2025
Video: Insights from Chief Scientific Officer Stefan Randl at CPHI Frankfurt 2025
Sign up to stay up to date on Siegfried and our business performance.